Literature DB >> 17014361

Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004).

Karla C L Lee1, Victoria J Lipscomb, Christopher R Lamb, Susan P Gregory, Javier Guitian, Daniel J Brockman.   

Abstract

OBJECTIVE: To determine whether hepatic portal vascularity, as assessed by intraoperative mesenteric portovenography (IMP), is related to outcome in dogs undergoing attenuation of single congenital portosystemic shunts (CPSSs).
DESIGN: Retrospective case series. ANIMALS: 45 dogs, each with a single CPSS, in which IMP was performed before and after temporary complete occlusion of the shunting vessel and that underwent complete (17 dogs) or partial (28 dogs) CPSS attenuation (surgery 1). PROCEDURES: Medical records were reviewed for signalment, clinical history, and bile acids stimulation test results. Intrahepatic portal vessel (IPV) opacification in pre- and postocclusion portovenograms was graded to determine whether the degree of opacification was correlated with the degree of shunt attenuation, clinical or biochemical factors, or long-term clinical outcome. In 17 of 28 dogs that had partial CPSS attenuation, these procedures were subsequently repeated (surgery 2) to achieve complete (14 dogs) or further partial (3 dogs) CPSS attenuation.
RESULTS: Compared with preattenuation findings, IPV opacification increased significantly after partial or complete CPSS attenuation. The degree of IPV opacification before and after CPSS occlusion (surgery 1) was greater in dogs that tolerated complete versus partial CPSS attenuation and was correlated positively with age. The degree of IPV opacification following CPSS occlusion (surgery 1) was maximal in all dogs without encephalopathy and was correlated negatively with follow-up preprandial serum bile acids concentrations and positively with clinical improvement. CONCLUSIONS AND CLINICAL RELEVANCE: Data suggest that IMP can be used to assess changes in IPV blood flow and help predict outcome following attenuation of single CPSSs in dogs.

Entities:  

Mesh:

Year:  2006        PMID: 17014361     DOI: 10.2460/javma.229.7.1122

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Attenuation of congenital portosystemic shunt reduces inflammation in dogs.

Authors:  Michael S Tivers; Ian Handel; Adam G Gow; Victoria J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

2.  Markers of angiogenesis associated with surgical attenuation of congenital portosystemic shunts in dogs.

Authors:  M S Tivers; A K House; K C Smith; C P D Wheeler-Jones; V J Lipscomb
Journal:  J Vet Intern Med       Date:  2014-08-08       Impact factor: 3.333

Review 3.  Treatment of congenital extrahepatic portosystemic shunts in dogs: A systematic review and meta-analysis.

Authors:  Gonçalo Serrano; Marios Charalambous; Nausikaa Devriendt; Hilde de Rooster; Femke Mortier; Dominique Paepe
Journal:  J Vet Intern Med       Date:  2019-08-31       Impact factor: 3.333

4.  Diagnosis of post-attenuation neurological signs syndrome in a cat with refractory status epilepticus and clinical response to therapeutic plasma exchange.

Authors:  Lisa Niemann; Katrin Beckmann; Claudia Iannucci; Adriano Wang Leandro; Alessio Vigani
Journal:  JFMS Open Rep       Date:  2022-09-17

5.  Genome-wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs.

Authors:  Lindsay Van den Bossche; Frank G van Steenbeek; Maarten F Weber; Bart Spee; Louis C Penning; Freek J van Sluijs; Flin Zomerdijk; Marian J A Groot Koerkamp; Jan Rothuizen; Iwan A Burgener; Anne Kummeling
Journal:  J Vet Intern Med       Date:  2018-05-17       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.